J Lingappa

Summary

Publications

  1. ncbi Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters
    Jairam R Lingappa
    University of Washington 325 Ninth Avenue, Box 359927 Seattle, WA 98104, USA
    AIDS Res Hum Retroviruses 29:164-71. 2013
  2. ncbi Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk
    Jairam R Lingappa
    Department of Global Health, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 5:e12598. 2010
  3. ncbi Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans
    J Lingappa
    Department of Global Health, University of Washington, Seattle, WA 98102, USA
    Int J STD AIDS 21:611-6. 2010
  4. ncbi Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure
    Jairam R Lingappa
    Department of Global Health, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 6:e28632. 2011
  5. ncbi Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial
    Jairam R Lingappa
    Department of Global Health, Seattle, WA, USA
    Lancet 375:824-33. 2010

Detail Information

Publications5

  1. ncbi Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters
    Jairam R Lingappa
    University of Washington 325 Ninth Avenue, Box 359927 Seattle, WA 98104, USA
    AIDS Res Hum Retroviruses 29:164-71. 2013
    ..Acyclovir use, BV among women source partners, and circumcision among male source partners may alter the set point by affecting transmitted virus inoculum in the source partners' genital compartment...
  2. ncbi Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk
    Jairam R Lingappa
    Department of Global Health, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 5:e12598. 2010
    ....
  3. ncbi Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans
    J Lingappa
    Department of Global Health, University of Washington, Seattle, WA 98102, USA
    Int J STD AIDS 21:611-6. 2010
    ..001). Of commercially available HSV-2 serological assays, Kalon alone, or Focus ELISA followed by Biokit confirmation perform best. Improved HSV-2 assays are needed for HSV-2 and HIV-1 public health activities in Africa...
  4. ncbi Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure
    Jairam R Lingappa
    Department of Global Health, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 6:e28632. 2011
    ..To minimize misclassification of HIV-1 risk, we quantified HIV-1 exposure, using data including plasma HIV-1 concentrations, gender, and condom use...
  5. ncbi Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial
    Jairam R Lingappa
    Department of Global Health, Seattle, WA, USA
    Lancet 375:824-33. 2010
    ..Daily suppression of this herpes virus reduces plasma HIV-1 concentrations, but whether it delays HIV-1 disease progression is unknown. We investigated the effect of acyclovir on HIV-1 progression...